MY146628A - Novel crystalline anhydride with anticholinergic effect - Google Patents
Novel crystalline anhydride with anticholinergic effectInfo
- Publication number
- MY146628A MY146628A MYPI20044518A MYPI20044518A MY146628A MY 146628 A MY146628 A MY 146628A MY PI20044518 A MYPI20044518 A MY PI20044518A MY PI20044518 A MYPI20044518 A MY PI20044518A MY 146628 A MY146628 A MY 146628A
- Authority
- MY
- Malaysia
- Prior art keywords
- novel crystalline
- crystalline anhydride
- anhydride
- anticholinergic effect
- producing
- Prior art date
Links
- 150000008064 anhydrides Chemical class 0.000 title abstract 3
- 230000001078 anti-cholinergic effect Effects 0.000 title 1
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960000257 tiotropium bromide Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
THE INVENTION PROVIDES A NOVEL CRYSTALLINE ANHYDRIDE OF TIOTROPIUM BROMIDE, A METHOD FOR PRODUCING SAID ANHYDRIDE AND THE USE THEREOF FOR PRODUCING A MEDICAMENT FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES, IN PARTICULAR, FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03025077 | 2003-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY146628A true MY146628A (en) | 2012-09-14 |
Family
ID=34530662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20044518A MY146628A (en) | 2003-11-03 | 2004-11-01 | Novel crystalline anhydride with anticholinergic effect |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1682542B1 (en) |
| JP (1) | JP4553902B2 (en) |
| KR (2) | KR101313904B1 (en) |
| CN (1) | CN100509809C (en) |
| AR (1) | AR046319A1 (en) |
| AT (1) | ATE453641T1 (en) |
| AU (1) | AU2004285684B2 (en) |
| BR (1) | BRPI0415636A (en) |
| CA (1) | CA2544352C (en) |
| CO (1) | CO5690641A2 (en) |
| CY (1) | CY1110339T1 (en) |
| DE (1) | DE502004010602D1 (en) |
| DK (1) | DK1682542T3 (en) |
| EA (1) | EA008587B1 (en) |
| EC (1) | ECSP066543A (en) |
| ES (1) | ES2338563T3 (en) |
| HR (1) | HRP20100029T1 (en) |
| IL (1) | IL175126A (en) |
| ME (1) | ME00349B (en) |
| MX (1) | MX272045B (en) |
| MY (1) | MY146628A (en) |
| NO (1) | NO20062569L (en) |
| NZ (1) | NZ547581A (en) |
| PE (1) | PE20050996A1 (en) |
| PL (1) | PL1682542T3 (en) |
| PT (1) | PT1682542E (en) |
| RS (2) | RS51599B (en) |
| SI (1) | SI1682542T1 (en) |
| TW (1) | TWI336330B (en) |
| UA (1) | UA82909C2 (en) |
| UY (1) | UY28596A1 (en) |
| WO (1) | WO2005042527A1 (en) |
| ZA (1) | ZA200602344B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1879888A2 (en) * | 2005-05-02 | 2008-01-23 | Boehringer Ingelheim International GmbH | Crystalline forms of tiotropium bromide |
| RU2453547C2 (en) * | 2005-12-19 | 2012-06-20 | Сикор Инк. | Novel forms of tiotropium bromide and synthesis methods thereof |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| PT1869035E (en) * | 2005-12-19 | 2013-01-10 | Sicor Inc | Novel crystalline form of tiotropium bromide and process for preparation thereof |
| KR20080083060A (en) * | 2006-01-04 | 2008-09-12 | 베링거 인겔하임 인터내셔날 게엠베하 | Use of tiotropium salt in the treatment of moderately persistent asthma |
| CN100999521B (en) * | 2006-01-13 | 2010-12-08 | 江苏正大天晴药业股份有限公司 | crystalline anticholinergic tiotropium bromide |
| US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| CN101032484B (en) * | 2007-04-02 | 2010-05-26 | 南京卡文迪许生物工程技术有限公司 | A kind of tiotropium bromide capsule type inhalation powder spray |
| GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| BRPI0916047A2 (en) * | 2008-11-04 | 2015-11-10 | Cipla Ltd | aerosol pharmaceutical composition, use of an aerosol pharmaceutical composition, method for treating severe, moderate or mild acute or chronic symptoms, or for prophylactic treatment of a respiratory disorder, aerosol pharmaceutical dispenser, process for manufacturing an aerosol pharmaceutical dispenser and process for making a complex of an active agent and an adjuvant |
| AU2009312582B2 (en) * | 2008-11-04 | 2014-03-27 | Cipla Limited | Tiotropium bromide having a low degree of crystallinity |
| CA2768553C (en) | 2009-08-07 | 2016-08-02 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| TR201111589A2 (en) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropium bromide anhydrous crystal form. |
| CZ304368B6 (en) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Tiotropium bromide mixed solvate and process for preparing thereof |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| ES2620758T3 (en) | 2012-11-05 | 2017-06-29 | Zentiva K.S. | Tiotropium Solvate Stabilization |
| EP2913332A1 (en) | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| WO2017138896A1 (en) | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
| EP4108230A1 (en) | 2021-06-24 | 2022-12-28 | Laboratoires SMB | New dry powder composition of tiotropium for inhalation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| AU2002214996B2 (en) * | 2000-10-12 | 2007-03-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| DE10111843A1 (en) * | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Compounds for the treatment of inflammatory diseases |
| CA2450961C (en) * | 2001-06-22 | 2010-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
-
2004
- 2004-10-29 WO PCT/EP2004/012269 patent/WO2005042527A1/en not_active Ceased
- 2004-10-29 DE DE502004010602T patent/DE502004010602D1/en not_active Expired - Lifetime
- 2004-10-29 ES ES04791029T patent/ES2338563T3/en not_active Expired - Lifetime
- 2004-10-29 KR KR1020127007695A patent/KR101313904B1/en not_active Expired - Fee Related
- 2004-10-29 PT PT04791029T patent/PT1682542E/en unknown
- 2004-10-29 UA UAA200605766A patent/UA82909C2/en unknown
- 2004-10-29 RS RS20060291A patent/RS51599B/en unknown
- 2004-10-29 CN CNB200480032521XA patent/CN100509809C/en not_active Expired - Lifetime
- 2004-10-29 CA CA2544352A patent/CA2544352C/en not_active Expired - Fee Related
- 2004-10-29 EP EP04791029A patent/EP1682542B1/en not_active Expired - Lifetime
- 2004-10-29 AU AU2004285684A patent/AU2004285684B2/en not_active Ceased
- 2004-10-29 JP JP2006537208A patent/JP4553902B2/en not_active Expired - Lifetime
- 2004-10-29 BR BRPI0415636-6A patent/BRPI0415636A/en not_active IP Right Cessation
- 2004-10-29 KR KR1020067010918A patent/KR101285571B1/en not_active Expired - Fee Related
- 2004-10-29 ME MEP-2008-517A patent/ME00349B/en unknown
- 2004-10-29 EA EA200600853A patent/EA008587B1/en unknown
- 2004-10-29 AT AT04791029T patent/ATE453641T1/en active
- 2004-10-29 RS YUP-2006/0291A patent/RS20060291A/en unknown
- 2004-10-29 PE PE2004001047A patent/PE20050996A1/en active IP Right Grant
- 2004-10-29 PL PL04791029T patent/PL1682542T3/en unknown
- 2004-10-29 DK DK04791029.4T patent/DK1682542T3/en active
- 2004-10-29 SI SI200431356T patent/SI1682542T1/en unknown
- 2004-10-29 NZ NZ547581A patent/NZ547581A/en not_active IP Right Cessation
- 2004-10-29 HR HR20100029T patent/HRP20100029T1/en unknown
- 2004-11-01 MY MYPI20044518A patent/MY146628A/en unknown
- 2004-11-02 TW TW093133282A patent/TWI336330B/en not_active IP Right Cessation
- 2004-11-03 UY UY28596A patent/UY28596A1/en not_active Application Discontinuation
- 2004-11-03 AR ARP040104040A patent/AR046319A1/en unknown
-
2006
- 2006-03-22 ZA ZA200602344A patent/ZA200602344B/en unknown
- 2006-04-24 IL IL175126A patent/IL175126A/en active IP Right Grant
- 2006-05-02 CO CO06041173A patent/CO5690641A2/en not_active Application Discontinuation
- 2006-05-03 EC EC2006006543A patent/ECSP066543A/en unknown
- 2006-05-03 MX MXPA06004940 patent/MX272045B/en active IP Right Grant
- 2006-06-02 NO NO20062569A patent/NO20062569L/en not_active Application Discontinuation
-
2010
- 2010-02-09 CY CY20101100120T patent/CY1110339T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108326T1 (en) | A NEW COMBINATION OF ANTI-CLINICAL AND BREATHING FOR MENTAL RESPIRATORY DISEASES | |
| UA83813C2 (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate | |
| PT1462100E (en) | Composition comprising formoterol and a glucocorticosteroid | |
| NO20062569L (en) | New crystalline anhydrides with anticholinergic effect | |
| TW200708513A (en) | Novel crystalline forms of tiotropium bromide | |
| WO2006117300A3 (en) | Crystalline forms of tiotropium bromide | |
| IL199022A0 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
| CY1114157T1 (en) | TYPES OF SILVER, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL CONTAINERS | |
| SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
| WO2011093819A3 (en) | New pharmaceutical combination comprising tiotropium | |
| NO20073909L (en) | Nebulized formulation | |
| IL189182A0 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
| WO2004047796A3 (en) | Pulverulent formulation for inhalation containing tiotropium | |
| MXPA04007294A (en) | Composition for inhalation. | |
| EP1651170A4 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2005007134A8 (en) | Powdery formulations for inhalation, containing a novel anticholinergic agent | |
| HK1116096A (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
| CY1113392T1 (en) | NEW CRYSTAL FORMS OF TIOTROPIO BRUMIDE | |
| ZA200801407B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma | |
| ZA200801408B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma |